83 related articles for article (PubMed ID: 23628037)
1. [Expressions of VEGF and CXCR4 in diffuse large B cell lymphoma and their clinical significances].
Guo Q; Wang JJ; Li F; Yang HL; Yu Y; Zhao ZG; Wang XF; Wang YF; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):383-6. PubMed ID: 23628037
[TBL] [Abstract][Full Text] [Related]
2. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma].
Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL
Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230
[TBL] [Abstract][Full Text] [Related]
3. CXCR4 and CCR7 Expression in Primary Nodal Diffuse Large B-Cell Lymphoma-A Clinical and Immunohistochemical Study.
Du H; Zhang L; Li G; Liu W; Tang W; Zhang H; Luan J; Gao L; Wang X
Am J Med Sci; 2019 Apr; 357(4):302-310. PubMed ID: 30904045
[TBL] [Abstract][Full Text] [Related]
4. [Ki-67 proliferative index in non-Hodgkin's lymphoma and its clinical significance].
Li J; Hu R; Liao AJ; Shi HY; Yan W; Liu ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):935-9. PubMed ID: 21867618
[TBL] [Abstract][Full Text] [Related]
5. [Expression of VEGF and its significance in primary diffuse large B-cell lymphoma of the female genital system].
Tang QL; Jiang XF; Yang KZ; Li HG; Liu WP; Peng ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):48-51. PubMed ID: 19292043
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of Ki-67 in diffuse large B cell lymphoma].
Zhou Y; Zhao Y; Bo J; Li YF; Ma C; Shi YN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1162-6. PubMed ID: 24156426
[TBL] [Abstract][Full Text] [Related]
7. Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma.
Shen N; Yu Y; Zhang R; Guo Y; Liu M; Tan M; Liu J; Bai J; Li L; Liu K; Wang R; He J
Int J Clin Pract; 2022; 2022():2637581. PubMed ID: 36567775
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of tissue factor and vascular endothelial growth factor expressions on CD14+ monocytes in patients with non Hodgkin lymphoma].
Wang HX; Li XM; Han XH; Jiang YJ; Zhu GH; Zhuang WC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Aug; 33(4):427-31. PubMed ID: 21906453
[TBL] [Abstract][Full Text] [Related]
9. The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma: a retrospective study of 97 patients.
Ganjoo KN; Moore AM; Orazi A; Sen JA; Johnson CS; An CS
J Cancer Res Clin Oncol; 2008 Mar; 134(3):381-7. PubMed ID: 17694324
[TBL] [Abstract][Full Text] [Related]
10. FOXP1 expression and its clinicopathologic significance in nodal and extranodal diffuse large B-cell lymphoma.
Yu B; Zhou X; Li B; Xiao X; Yan S; Shi D
Ann Hematol; 2011 Jun; 90(6):701-8. PubMed ID: 21120478
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma].
Yang BY; Yong WB; Zhu J; Zheng W; Zhang YT; Wang XP; Meng SN
Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):174-6. PubMed ID: 15946571
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of miR-21 in diffuse large B cell lymphoma].
Li CH; Fu R; Wang YH; Song WJ; Ruan EB; Qu W; Wang HQ; Wang GJ; Song J; Wang XM; Wu YH; Xing LM; Liu H; Li LJ; Guan J; Shao ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):339-43. PubMed ID: 24763002
[TBL] [Abstract][Full Text] [Related]
13. Prognostic [corrected] significance of angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large B cell lymphoma and review of the literature.
Paydas S; Ergin M; Seydaoglu G; Erdogan S; Yavuz S
Leuk Res; 2009 Dec; 33(12):1627-35. PubMed ID: 19286254
[TBL] [Abstract][Full Text] [Related]
14. [Clinical Significance of TF and VEGF Expressions on Peripheral CD14 Positive Monocytes in Patients with Diffuse Large B Cell Lymphoma].
Jiang YJ; Zhu GH; He Y; Chai XX; Yang XY; Meng FJ; Zhuang WC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):67-73. PubMed ID: 30738449
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas.
Paydas S; Ergin M; Erdogan S; Seydaoglu G
Leuk Res; 2008 Sep; 32(9):1424-30. PubMed ID: 18282597
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of prognostic risk factors in patients with diffuse large B-cell lymphoma].
Yu ZP; Ding JH; Chen BA; Gao C; Wang LL; Chen Z
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):830-5. PubMed ID: 22339956
[TBL] [Abstract][Full Text] [Related]
17. Ocular adnexal diffuse large B-cell lymphoma: a multicenter international study.
Munch-Petersen HD; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Sniegowski MC; Vemuganti GK; Heegaard S
JAMA Ophthalmol; 2015 Feb; 133(2):165-73. PubMed ID: 25393033
[TBL] [Abstract][Full Text] [Related]
18. Significance of tumor burden, vascular endothelial growth factor, lactate dehydrogenase and beta-2 microglobulin serum levels in advanced diffuse large B cell lymphoma.
Milanovic N; Matkovic S; Ristic D; Jelic S; Petrovic M
J BUON; 2012; 17(3):497-501. PubMed ID: 23033288
[TBL] [Abstract][Full Text] [Related]
19. [Influence of transplantation and some clinical factors on prognosis of patients with diffuse large B-cell lymphoma].
Zhao SX; Han Y; Zhu Q; Wang Q; Zhang WJ; Chen XC; Sun AN; Jin ZM; Qiu HY; Tang XW; Fu ZZ; He GS; Miao M; Ma X; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):623-7. PubMed ID: 23815910
[TBL] [Abstract][Full Text] [Related]
20. Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP.
Wang Y; Li YJ; Jiang WQ; Rao HL; Huang JJ; Xia Y; Bi X; Sun P; Huang HQ; Lin TY; Guan ZZ; Li ZM
Ann Hematol; 2015 Nov; 94(11):1865-73. PubMed ID: 26327569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
